PRDM6 and neoplasm: To understand the clonal genetic events in tumour initiation, evolution and progression, we molecularly profiled a specific tumour cohort with a known amplification of MYCN or MYC or overexpression of PRDM6 (n = 16 primary, n = 4 relapses; Fig. 1a and Supplementary Table 1).